Parkinson’s Disease Drugs Market
Parkinson’s Disease Drugs Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Parkinson’s Disease Drugs Market Size and Growth
The Parkinson's Disease Drugs market is projected to reach a value of $6.1 billion by 2025, with a compound annual growth rate of 5.6%. Rising prevalence of Parkinson's Disease, increasing geriatric population, and advancements in drug development are driving market growth. Key players include AbbVie Inc., Teva Pharmaceuticals, and Novartis AG.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Novartis
◍ F. Hoffmann-La Roche
◍ AbbVie
◍ Teva Pharmaceutical Industries
◍ UCB Inc.
◍ STADA Arzneimittel
◍ GlaxoSmithKline
◍ Bausch Health
◍ Merck
◍ Impax Laboratories
The competitive landscape of Parkinson’s Disease Drugs Market includes Novartis, F. Hoffmann-La Roche, AbbVie, Teva Pharmaceutical Industries, UCB Inc., STADA Arzneimittel, GlaxoSmithKline, Bausch Health, Merck, and Impax Laboratories. These companies develop and market drugs for Parkinson's disease, contributing to the growth of the market.
- Novartis reported sales revenue of $47.6 billion in 2020.
- AbbVie reported sales revenue of $45.8 billion in 2020.
- Teva Pharmaceutical Industries reported sales revenue of $16.7 billion in 2020.
Request Sample Report
Market Segmentation
By Application
By Product
◍ Oral
Intestinal Infusion ◍ Hospital Pharmacy
Retail Pharmacy
Online Pharmacy Request Sample Report
Transdermal
Subcutaneous
Market Growth
Request Sample Report
$ X Billion USD
